JPMORGAN CHASE & CO - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$2,566
-23.9%
1,8330.0%0.00%
Q2 2023$3,373
-15.7%
1,8330.0%0.00%
Q1 2023$4,0001,833
+2518.6%
0.00%
Q4 2022$0700.0%0.00%
Q3 2022$0700.0%0.00%
Q2 2022$0700.0%0.00%
Q1 2022$0700.0%0.00%
Q4 2021$0700.0%0.00%
Q3 2021$0
-100.0%
70
-99.9%
0.00%
Q2 2021$341,000
-28.7%
107,720
-22.7%
0.00%
Q1 2021$478,000
+43.1%
139,272
+5.3%
0.00%
Q4 2020$334,000
+676.7%
132,215
+530.0%
0.00%
Q3 2020$43,000
+30.3%
20,988
+40.5%
0.00%
Q2 2020$33,000
-80.1%
14,941
-77.1%
0.00%
Q1 2020$166,000
+144.1%
65,293
+151.5%
0.00%
Q4 2019$68,000
+13.3%
25,962
+56.0%
0.00%
Q3 2019$60,000
+39.5%
16,637
+37.3%
0.00%
Q2 2019$43,000
+48.3%
12,121
+12.8%
0.00%
Q1 2019$29,000
-56.7%
10,744
-55.6%
0.00%
Q4 2018$67,000
-75.0%
24,192
-62.8%
0.00%
Q3 2018$268,000
+6.3%
65,077
+33.7%
0.00%
Q2 2018$252,000
-72.3%
48,691
-70.7%
0.00%
Q1 2018$910,000
+1163.9%
165,964
+1767.9%
0.00%
Q4 2017$72,000
-72.6%
8,885
-64.0%
0.00%
Q3 2017$263,000
+19.5%
24,677
-6.0%
0.00%
Q1 2017$220,000
+6.8%
26,241
-41.9%
0.00%
Q1 2016$206,000
+281.5%
45,167
+110.3%
0.00%
Q3 2013$54,000
+20.0%
21,476
-1.4%
0.00%
Q2 2013$45,00021,7760.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders